- Home
- Companies
- Hardy Diagnostics
- Products
- LifeSign - COVID-19/Flu Rapid Antigen ...
LifeSign - COVID-19/Flu Rapid Antigen Immunoassay
A rapid immunoassay for the simultaneous direct detection and differential diagnosis of SARS-CoV-2, Influenza Type A and Type B antigen from anterior nasal (AN) or nasopharyngeal (NP) swab specimens. Kit includes extraction buffer vials and flocked nasopharyngeal (NP) swabs for superior specimen collection and patient comfort, and provides a visual read-out in 15 minutes with no equipment needed! This product is CLIA waived.
Sensitivity and Specificity
SARS-CoV-2 Sensitivity 93.9%, Specificity 100%
Flu A Sensitivity 91.4%, Specificity 95.7%
Flu B Sensitivity 87.6%, Specificity 95.9%
Fast Results
Visual read-out in 15 minutes, and no equipment needed!
EUA & CLIA Waived
Authorized for use under an Emergency Use Authorization (EUA) and for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.
Kit includes extraction buffer vials and flocked nasopharyngeal (NP) swabs for superior specimen collection and patient comfor
Expiration Dating Memo
Failed to fetch Error: URL to the PDF file must be on exactly the same domain as the current web page. Click here for more info
Product SDS
Failed to fetch Error: URL to the PDF file must be on exactly the same domain as the current web page. Click here for more info
Provider Fact Sheet
Failed to fetch Error: URL to the PDF file must be on exactly the same domain as the current web page. Click here for more info
Patient Fact Sheet
Failed to fetch Error: URL to the PDF file must be on exactly the same domain as the current web page. Click here for more info
Procedure Card
Failed to fetch Error: URL to the PDF file must be on exactly the same domain as the current web page. Click here for more info